
The study assessed the clinical outcomes of high-intensity focused ultrasound (HIFU) with intraoperative prostate compression for patients with localized prostate cancer (PC). A total of 240 patients with clinically significant PC underwent treatment. Biochemical and pathological disease-free survival rates for low-, intermediate-, and high-risk groups were 93.7% and 92.2%, 88.5% and 91.6%, and 84.8% and 86.6%, respectively. Radical or systematic treatment-free survival rates were 96.1%, 94.4%, and 95.1%, respectively. While urinary and sexual function initially deteriorated at 1 month, it returned to preoperative levels after 3 to 6 months. The findings suggest that HIFU with prostate compression improves medium-term oncological outcomes with minimal functional decline.
Like
Save
Share